March 18, 2015

Errant Gene Therapeutics, LLC et al v. Sloan-Kettering Institute for Cancer Research

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. January 02, 2018

    Sloan Kettering Gets Trimmed Fees In IP Fight

    A New York federal judge ordered Errant Gene Therapeutics LLC to pay the Sloan Kettering Institute for Cancer Research $88,339 in attorneys' fees Tuesday after the biopharmaceutical company was sanctioned for using protected information from a gene therapy patent rights case in other suits.

5 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login